PSN821

· Prosidion Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PSN821, covering 2012-08-17 to 2012-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM) [Phase 2]